Form 4 for PCVX Vaxcyte, Inc.
Accepted 2024-09-18 00:00:00 ET · period of report 2024-09-17 · accession 0001649094-24-000069 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-09-18 | 2024-09-17 | PCVX | Loxam Teri | Dir | S - Sale+OE | $116.28 | -6,250 | 7,431 | -46% | -$726.7K |
| D | 2024-09-18 | 2024-09-17 | PCVX | Loxam Teri | Dir | M - OptEx | $22.70 | +6,250 | 13.4K | +87% | +$141.9K |
| D | 2024-09-18 | 2024-09-17 | PCVX | Loxam Teri | Dir | M - OptEx | $0.00 | -6,250 | 12.5K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-17 | S | D | 241 | $114.64 | 13,184 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $113.93 to $114.74. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2024-09-17 | M | A | 6,250 | $22.70 | 13,425 | D | — | — | |
| 3 | Common | Common Stock | 2024-09-17 | S | D | 256 | $117.51 | 7,175 | D | — | — | |
| 4 | Common | Common Stock | 2024-09-17 | S | D | 1,445 | $115.32 | 11,739 | D | — | — | (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $115.04 to $115.64. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2024-09-17 | S | D | 4,308 | $116.62 | 7,431 | D | — | — | (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $116.25 to $117.04. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 6 | Derivative | Stock Option (right to buy) | 2024-09-17 | M | D | 6,250 | $0.00 | 12,500 | D | $22.70 · — to 2032-05-31 | 6,250 Common Stock | (F5) Option is fully vested and exercisable. |